Financials in USD. Standardized financial statements.
A compact view of how Journey Medical Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $61.86M | $56.13M | $79.18M | $73.67M | $63.13M | $44.53M | $34.92M | $42.34M | $4.54M | $22.59M |
| Revenue Growth? | +10.2% | -29.1% | +7.5% | +16.7% | +41.8% | +27.5% | -17.5% | +832.4% | -79.9% | 0.0% |
| Cost of Revenue? | $25.18M | $20.88M | $26.66M | $30.77M | $32.08M | $14.59M | $10.53M | $1.18M | $0 | $0 |
| Gross Profit? | $36.68M | $35.26M | $52.52M | $42.89M | $31.05M | $29.94M | $24.39M | $41.16M | $4.54M | $22.59M |
| Gross Margin? | +59.3% | +62.8% | +66.3% | +58.2% | +49.2% | +67.2% | +69.8% | +97.2% | +100.0% | +100.0% |
| Operating Expenses? | $44.85M | $48.93M | $54.59M | $70.41M | $65.93M | $22.09M | $19.13M | $255.15M | $304.87M | $113.21M |
| Operating Income? | -$8.17M | -$13.68M | -$2.07M | -$27.52M | -$34.88M | $7.85M | $5.26M | -$213.98M | -$300.33M | -$90.62M |
| EBITDA? | -$3.83M | -$8.40M | $1.92M | -$23.18M | -$32.77M | $9.28M | $6.44M | -$205.54M | -$294.78M | -$87.42M |
| Income Before Tax | -$11.37M | -$14.61M | -$3.63M | -$29.57M | -$42.36M | $7.15M | $5.00M | -$221.73M | -$303.26M | -$89.08M |
| Income Tax Expense | $60,000 | $61,000 | $221,000 | $63,000 | $1.63M | $1.87M | $1.38M | -$194,000 | $0 | $0 |
| Net Income? | -$11.43M | -$14.67M | -$3.85M | -$29.63M | -$43.99M | $5.28M | $3.63M | -$221.54M | -$303.26M | -$89.08M |
| EPS? | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-2.54 | $0.32 | $0.22 | $-5.27 | $-7.48 | $-1.76 |
| Diluted EPS? | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-2.54 | $0.32 | $0.22 | $-5.27 | $-7.48 | $-2.70 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality